Gastric antisecretory drugs induce leukocyte-endothelial cell interactions through gastrin release and activation of CCK-2 receptors

Journal of Pharmacology and Experimental Therapeutics

Volumn 323, Issue 1, 2007, Pages 406-413

  Álvarez, Ángeles ^a   Ibiza, M Sales ^a   Andrade, Mario M ^a   Blas García, Ana ^a   Calatayud, Sara ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIULCER AGENT; CD11B ANTIGEN; CD18 ANTIGEN; CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; FAMOTIDINE; GASTRIN; GLYCOPROTEIN P 15095; L SELECTIN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; OMEPRAZOLE; PROGLUMIDE; STOMACH SECRETION INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; ATROPHIC GASTRITIS; CELL INTERACTION; CELL MIGRATION; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG EFFICACY; DRUG RECEPTOR BINDING; ENDOTHELIUM CELL; GASTRIN BLOOD LEVEL; GASTRIN RELEASE; GASTRITIS; GRANULOCYTE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; IN VIVO STUDY; INFLAMMATION; INTERSTITIUM; LEUKOCYTE; LEUKOCYTE ADHERENCE; LEUKOCYTE ROLLING; LYMPHOCYTE; MALE; MESENTERIC VEIN; MICROSCOPY; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; SINGLE DRUG DOSE; STOMACH MUCOSA;

ANIMALS; ANTI-ULCER AGENTS; CELL COMMUNICATION; CHEMOTAXIS, LEUKOCYTE; ENDOTHELIAL CELLS; FLOW CYTOMETRY; GASTRIC MUCOSA; GASTRINS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LEUKOCYTES; MALE; MICROSCOPY, VIDEO; PROTON PUMPS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CHOLECYSTOKININ B;

EID: 34548851488     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.107.122754     Document Type: Article

References (34)

1. Akdis CA and Simons FE (2006) Histamine receptors are hot in immunopharmacology. Eur J Pharmacol 533:69-76.
2. Alvarez A, Hermenegildo C, Issekutz AC, Esplugues JV, and Sanz MJ (2002) Estrogens inhibit angiotensin II-induced leukocyte-endothelial cell interactions in vivo via rapid endothelial nitric oxide synthase and cyclooxygenase activation. Circ Res 91:1142-1150.
3. Alvarez A, Ibiza S, Hernandez C, Alvarez-Barrientos A, Esplugues JV, and Calatayud S (2006) Gastrin induces leukocyte-endothelial cell interactions in vivo and contributes to the inflammation caused by Helicobacter pylori. FASEB J 20:2396-2398.
4. Asako H, Kurose I, Wolf R, Defrees S, Zheng ZL, Phillips ML, Paulson JC, and Granger DN (1994) Role of H1 receptors and P-selectin in histamine-induced leukocyte rolling and adhesion in postcapillary venules. J Clin Invest 93:1508-1515.
5. Blaser MJ and Atherton JC (2004) Helicobacter pylori persistence: biology and disease. J Clin Invest 113:321-333.
6. Calatayud S, Sanz MJ, Canet A, Bello R, de Rojas FD, and Esplugues JV (1999) Mechanisms of gastroprotection by transdermal nitroglycerin in the rat. Br J Pharmacol 127:1111-1118.
7. Clarke PA, Dickson JH, Harris JC, Grabowska A, and Watson SA (2006) Gastrin enhances the angiogenic potential of endothelial cells via modulation of heparin-binding epidermal-like growth factor. Cancer Res 66:3504-3512.
8. Decktor DL, Pendleton RG, Kellner AT, and Davis MA (1989) Acute effects of ranitidine, famotidine and omeprazole on plasma gastrin in the rat. J Pharmacol Exp Ther 249:1-5.
9. Dockray G, Dimaline R, and Varro A (2005) Gastrin: old hormone, new functions. Pflugers Arch 449:344-355.
10. Eissele R, Brunner G, Simon B, Solcia E, and Arnold R (1997) Gastric mucosa during treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophil cell hyperplasia. Gastroenterology 112:707-717.
11. Fox JG and Wang TC (2007) Inflammation, atrophy, and gastric cancer. J Clin Invest 117:60-69.
12. Handa O, Yoshida N, Fujita N, Tanaka Y, Ueda M, Takagi T, Kokura S, Naito Y, Okanoue T, and Yoshikawa T (2006) Molecular mechanisms involved in anti-inflammatory effects of proton pump inhibitors. Inflamm Res 55:476-480.
13. Karalis K, Mastorakos G, Chrousos GP, and Tolis G (1994) Somatostatin analogs suppress the inflammatory reaction in-vivo. J Clin Invest 93:2000-2006.
14. Kuipers EJ, Uyterlinde AM, Pena AS, Hazenberg HJ, Bloemena E, Lindeman J, Klinkenberg-Knol EC, and Meuwissen SG (1995) Increase of Helicobacter pyloriassociated corpus gastritis during acid suppressive therapy: implications for long-term safety. Am J Gastroenterol 90:1401-1406.
15. Lee DY, Lee I, and Lee MG (2007) Pharmacokinetics of omeprazole after intravenous and oral administration to rats with liver cirrhosis induced by dimethylnitrosamine. Int J Pharm 330:37-44.
16. Lefranc F, Mijatovic T, Mathieu V, Rorive S, Decaestecker C, Debeir O, Brotchi J, Van Ham P, Salmon I, and Kiss R (2004) Characterization of gastrin-induced proangiogenic effects in vivo in orthotopic U373 experimental human glioblastomas and in vitro in human umbilical vein endothelial cells. Clin Cancer Res 10:8250-8265.
17. Liu Y, Shaw SK, Ma S, Yang L, Luscinskas FW, and Parkos CA (2004) Regulation of leukocyte transmigration: cell surface interactions and signaling events. J Immunol 172:7-13.
18. Logan RP, Walker MM, Misiewicz JJ, Gummett PA, Karim QN, and Baron JH (1995) Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole. Gut 36:12-16.
19. Meining A, Bosseckert H, Caspary WF, Nauert C, and Stolte M (1997) H2-receptor antagonists and antacids have an aggravating effect on Helicobacter pylori gastritis in duodenal ulcer patients. Aliment Pharmacol Ther 11:729-734.
20. Meining A, Kiel G, and Stolte M (1998) Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during and after 12 months of treatment with ranitidine and lansoprazole in patients with duodenal ulcer disease. Aliment Pharmacol Ther 12:735-740.
21. Moayyedi P, Wason C, Peacock R, Walan A, Bardhan K, Axon AT, and Dixon MF (2000) Changing patterns of Helicobacter pylori gastritis in long-standing acid suppression. Helicobacter 5:206-214.
22. Sacerdote P, Ruff MR, and Pert CB (1988) Cholecystokinin and the immune system: receptor-mediated chemotaxis of human and rat monocytes. Peptides 9:29-34.
23. Sacerdote P, Wiedermann CJ, Wahl LM, Pert CB, and Ruff MR (1991) Visualization of cholecystokinin receptors on a subset of human monocytes and in rat spleen. Peptides 12:167-176.
24. Schenk BE, Kuipers EJ, Nelis GF, Bloemena E, Thijs JC, Snel P, Luckers AE, Klinkenberg-Knol EC, Festen HP, Viergever PP, et al. (2000) Effect of Helicobacter pylori eradication on chronic gastritis during omeprazole therapy. Gut 46:615-621.
25. Schmitz F, Schrader H, Otte JM, Schmitz H, Stuber E, Herzig KH, and Schmidt WE (2001) Identification of CCK-B/gastrin receptor splice variants in human peripheral blood mononuclear cells. Regul Pept 101:25-33.
26. Stolte M, Meining A, Schmitz JM, Alexandridis T, and Seifert E (1998) Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during 12 months of treatment with omeprazole and lansoprazole in patients with gastrooesophageal reflux disease. Aliment Pharmacol Ther 12:247-253.
27. Takaishi S, Cui GL, Frederick DM, Carlson JE, Houghton J, Varro A, Dockray GJ, Ge ZM, Whary MT, Rogers AB, et al. (2005) Synergistic inhibitory effects of gastrin and histamine receptor antagonists on Helicobacter-induced gastric cancer. Gastroenterology 128:1965-1983.
28. Walsh JH (1994) Gastrin, in Gut Peptides: Biochemistry and Physiology (Walsh JH and Dockray GJ eds) pp 75-121, Raven Press, New York.
29. Watson SA, Grabowska AM, El Zaatari M, and Takhar A (2006) Gastrin - active participant or bystander in gastric carcinogenesis. Nat Rev Cancer 6:936-946.
30. Weigert N, Schaffer K, Schusdziarra V, Classen M, and Schepp W (1996) Gastrin secretion from primary cultures of rabbit antral G cells: stimulation by inflammatory cytokines. Gastroenterology 110:147-154.
31. Yoshida N, Yoshikawa T, Tanaka Y, Fujita N, Kassai K, Naito Y, and Kondo M (2000) A new mechanism for anti-inflammatory actions of proton pump inhibitors-inhibitory effects on neutrophil-endothelial cell interactions. Aliment Pharmacol Ther 14 (Suppl 1):74-81.
32. Zavros Y, Rathinavelu S, Kao JY, Todisco A, Del Valle J, Weinstock JV, Low MJ, and Merchant JL (2003) Treatment of Helicobacter gastritis with IL-4 requires somatostatin. Proc Natl Acad Sci U S A 100:12944- 12949.
33. Zavros Y, Rieder G, Ferguson A, Samuelson LC, and Merchant JL (2002) Genetic or chemical hypochlorhydria is associated with inflammation that modulates parietal and G-cell populations in mice. Gastroenterology 122:119-133.
34. Zhang M, Thurmond RL, and Dunford PJ (2007) The histamine H(4) receptor: a novel modulator of inflammatory and immune disorders. Pharmacol Ther 113: 594-606.